![David Reese](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Reese
Vorstandsvorsitzender bei
KAI Pharmaceuticals, Inc.
Vermögen: 15 Mio $ am 30.06.2026
Profil
Der Gründer von Translational Oncology Research International, Inc. David M. Reese ist Executive Vice President-Research & Development bei Amgen, Inc. Dr. Reese hatte zuvor die Position des Director-Clinical Research bei Breast Cancer International Research Group Ltd. und des Director-Clinical Research bei Translational Research In Oncology inne. Er erhielt einen Bachelor-Abschluss vom Harvard College und einen Bachelor-Abschluss vom University of Cincinnati College of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AMGEN INC. 0.01% | 07.05.2026 | 42’256 ( 0.01% ) | 15 Mio $ | 30.06.2026 |
Aktive Positionen von David Reese
| Unternehmen | Position | Beginn |
|---|---|---|
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Präsident | - |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Direktor/Vorstandsmitglied | - |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Vorstandsvorsitzender | - |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Präsident | - |
Research!America
 Research!America Miscellaneous Commercial ServicesCommercial Services Operates as a lobbying firm | Direktor/Vorstandsmitglied | 22.04.2023 |
Ehemalige bekannte Positionen von David Reese
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.06.2026 |
Translational Oncology Research International, Inc.
 Translational Oncology Research International, Inc. Pharmaceuticals: MajorHealth Technology Engages in processing drugs in pharmaceutical preparations | Gründer | 01.01.2005 |
Breast Cancer International Research Group Ltd.
 Breast Cancer International Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Breast Cancer International Research Group Ltd. is a Canadian company. 'The company is based in Edmonton, Canada. The company was founded by Alessandro Riva. | Corporate Officer/Principal | 01.01.2003 |
| CHEMOCENTRYX, INC. | Vorstandsvorsitzender | - |
| ░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von David Reese
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Alantos Pharmaceuticals Holding, Inc.
Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Commercial Services |
Research!America
Research!America Miscellaneous Commercial ServicesCommercial Services Operates as a lobbying firm | Commercial Services |
The University of Cincinnati College of Medicine
 The University of Cincinnati College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Translational Research In Oncology
 Translational Research In Oncology Miscellaneous Commercial ServicesCommercial Services Operates as an oncology clinical research organization | Commercial Services |
Translational Oncology Research International, Inc.
Translational Oncology Research International, Inc. Pharmaceuticals: MajorHealth Technology Engages in processing drugs in pharmaceutical preparations | Health Technology |
Breast Cancer International Research Group Ltd.
Breast Cancer International Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Breast Cancer International Research Group Ltd. is a Canadian company. 'The company is based in Edmonton, Canada. The company was founded by Alessandro Riva. | Commercial Services |
